CN104161194B - For reducing the feedstuff of cholesterol content in eggs - Google Patents
For reducing the feedstuff of cholesterol content in eggs Download PDFInfo
- Publication number
- CN104161194B CN104161194B CN201410440694.0A CN201410440694A CN104161194B CN 104161194 B CN104161194 B CN 104161194B CN 201410440694 A CN201410440694 A CN 201410440694A CN 104161194 B CN104161194 B CN 104161194B
- Authority
- CN
- China
- Prior art keywords
- semen
- raw material
- feedstuff
- feed additive
- eggs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims abstract description 125
- 235000012000 cholesterol Nutrition 0.000 title claims abstract description 44
- 235000013601 eggs Nutrition 0.000 title claims abstract description 42
- 210000000582 semen Anatomy 0.000 claims abstract description 70
- 239000003674 animal food additive Substances 0.000 claims abstract description 34
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 13
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 13
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 13
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 13
- 241000282894 Sus scrofa domesticus Species 0.000 claims abstract description 13
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000004473 Threonine Substances 0.000 claims abstract description 13
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 13
- 229960003178 choline chloride Drugs 0.000 claims abstract description 13
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 13
- 235000012343 cottonseed oil Nutrition 0.000 claims abstract description 13
- 235000012054 meals Nutrition 0.000 claims abstract description 13
- 229960003237 betaine Drugs 0.000 claims abstract description 12
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 12
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims abstract description 11
- 235000019700 dicalcium phosphate Nutrition 0.000 claims abstract description 11
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 4
- 235000008521 threonine Nutrition 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 37
- 239000002994 raw material Substances 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 28
- 241000628997 Flos Species 0.000 claims description 24
- 229920000858 Cyclodextrin Polymers 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 20
- 241000218628 Ginkgo Species 0.000 claims description 12
- 235000011201 Ginkgo Nutrition 0.000 claims description 12
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 9
- 210000000232 gallbladder Anatomy 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 229920001503 Glucan Polymers 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000007670 refining Methods 0.000 claims description 6
- 238000010348 incorporation Methods 0.000 claims description 5
- 239000008188 pellet Substances 0.000 claims description 5
- 229930193551 sterin Natural products 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 229910052802 copper Inorganic materials 0.000 claims 2
- 239000010949 copper Substances 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 210000002969 egg yolk Anatomy 0.000 abstract description 16
- 102000002322 Egg Proteins Human genes 0.000 abstract description 15
- 108010000912 Egg Proteins Proteins 0.000 abstract description 15
- 235000013345 egg yolk Nutrition 0.000 abstract description 15
- 230000000694 effects Effects 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 26
- 239000008280 blood Substances 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 210000000214 mouth Anatomy 0.000 description 22
- 239000000341 volatile oil Substances 0.000 description 18
- 235000019197 fats Nutrition 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 239000000284 extract Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 229910000365 copper sulfate Inorganic materials 0.000 description 7
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 239000010282 Emodin Substances 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 235000013330 chicken meat Nutrition 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000001047 pyretic effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 238000001291 vacuum drying Methods 0.000 description 5
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- -1 phosphoric acid hydrogen Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- UBAXRAHSPKWNCX-UHFFFAOYSA-N diallyl trisulfide Chemical compound C=CCSSSCC=C UBAXRAHSPKWNCX-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000013433 lightheadedness Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000722818 Aralia Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 1
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000488874 Sonchus Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000026636 chronic pulmonary heart disease Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 230000010235 enterohepatic circulation Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229940111260 ginkgo folium Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Abstract
The invention provides a kind of feedstuff for reducing cholesterol content in eggs, it includes the feed additive for reducing cholesterol content in eggs that Semen Maydis, Semen Tritici aestivi, bean cake, cottonseed meal, calcium hydrogen phosphate, threonine, Adeps Sus domestica, choline chloride, glycine betaine, Sal, vitamin premix DV22H and the present invention provide.Contained the feedstuff of this feed additive by feeding, can significantly reduce the cholesterol level in egg yolk.
Description
Technical field
The present invention relates to field of feed, particularly relate to a kind of feedstuff for improving cholesterol content in eggs.
Background technology
Along with the raising of people's living standard, people increasingly focus on the nutritive value of egg, and egg contains needed by human body
All kinds of nutrient substance wanted.Egg not only nutrient categories is enriched, and balance of nutrients is reasonable, and biological value is high, but people
Worry that Cholesterol Content in Egg Yolk higher (200～300 mg/piece) can affect middle-aged and elderly people and hypercholesterolemia patient
Health, hypercholesterolemia meals are closely related with atherosclerosis, therefore, reduce cholesterol content in eggs and have actual meaning
Justice.The content of the cholesterol of egg weighs the important indicator of Egg Quality to become.On market in the urgent need to a kind of low cholesterol and
There is the functional Egg of certain health-care effect (such as high selenium, high calcium etc.).By Nutrition and Metabolism control measures, gallbladder can be produced
The egg of sterin is to meet consumer demand.
Egg cholesterol mainly concentrates in egg yolk, and the cholesterol level in egg yolk is by the shadow of h and E factor
Ring, the cholesterol in product can be reduced by the interpolation etc. of the selection of kind, the adjustment of feed ingredient and medicine, wherein pass through
The change of feed ingredient and the method adding reduction yolk cholesterol of medicine are the emphasis of research.
Summary of the invention
The technical problem to be solved is to provide a kind of feed additive and comprises raising of this feed additive
Material, by this feedstuff of feeding, can significantly reduce the cholesterol level in egg yolk.
For solving above-mentioned technical problem, the invention provides a kind of feedstuff for reducing cholesterol content in eggs, its
Including Semen Maydis, Semen Tritici aestivi, bean cake, cottonseed meal, calcium hydrogen phosphate, threonine, Adeps Sus domestica, choline chloride, glycine betaine, Sal, vitamin premix
The feed additive for reducing cholesterol content in eggs that material DV22H and the present invention provide.
Wherein, in described feedstuff, the weight of each raw material is respectively Semen Maydis 50g ~ 55g, Semen Tritici aestivi 8g ~ 12g, bean cake 2g ~ 4g, cotton
Dregs of rice 3g ~ 5g, calcium hydrogen phosphate 0.5g ~ 1.5g, threonine 0.1g ~ 0.3g, Adeps Sus domestica 1g ~ 3g, choline chloride 0.05g ~ 0.15g, Radix Betae
What alkali 0.05g ~ 0.15g, Sal 0.3g ~ 0.5g, vitamin premix DV22H 0.2g ~ 0.4g and the present invention provided is used for reducing
Feed additive 2g ~ the 5g of cholesterol content in eggs.
Wherein, in described feedstuff, the total amount of each raw material is respectively Semen Maydis 53g, Semen Tritici aestivi 10g, bean cake 3g, cottonseed meal 4g, phosphoric acid hydrogen
Calcium 1g, threonine 0.2g, Adeps Sus domestica 2g, choline chloride 0.1g, glycine betaine 0.1g, Sal 0.4g, vitamin premix DV22H
The feed additive 3g for reducing cholesterol content in eggs that 0.3g and the present invention provide.
The raw material of the described feed additive for reducing cholesterol content in eggs includes that dextrinosan ,-Portugal gather
Sugar, copper sulfate and Chinese medicine composition extract-cyclodextrin inclusion compound product.
Wherein, in described feed additive, the weight of each raw material is respectively dextrinosan 20g ~ 30g ,-glucosan
35g ~ 45g, copper sulfate 5g ~ 15g and Chinese medicine composition extract-cyclodextrin inclusion compound product 300g ~ 400g.
The crude drug of described Chinese medicine composition extract-cyclodextrin inclusion compound product include Herb Gynostemmae Pentaphylli, Flos Lonicerae, Flos Hibisci Rosae-Sinensis,
Folium Crataegi, Folium Ginkgo, Semen Cassiae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Rhizoma Polygonati Odorati, Herba Artemisiae Scopariae, Semen Lepidii (Semen Descurainiae), Rhizoma Curcumae Longae, Radix Et Rhizoma Rhei, Bulbus Allii Macrostemonis, Thallus Laminariae (Thallus Eckloniae), Fructus Schisandrae Chinensis,
Bulbus Allii, Herba Sonchi Oleracei and Herba Moslae Soochowensis.
The weight of described each crude drug is respectively Herb Gynostemmae Pentaphylli 55g ~ 65g, Flos Lonicerae 30g ~ 40g, Flos Hibisci Rosae-Sinensis 20g ~ 30g, mountain
Short, bristly hair or beard leaf 25g ~ 35g, Folium Ginkgo 20g ~ 30g, Semen Cassiae 20g ~ 30g, Radix Polygoni Multiflori 25g ~ 35g, Radix Salviae Miltiorrhizae 15g ~ 25g, Rhizoma Polygonati Odorati 10g ~
20g, Herba Artemisiae Scopariae 10g ~ 20g, Semen Lepidii (Semen Descurainiae) 25g ~ 35g, Rhizoma Curcumae Longae 25g ~ 35g, Radix Et Rhizoma Rhei 10g ~ 20g, Bulbus Allii Macrostemonis 10g ~ 20g, Thallus Laminariae (Thallus Eckloniae) 15g ~
25g, Fructus Schisandrae Chinensis 25g ~ 35g, Bulbus Allii 20g ~ 30g, Herba Sonchi Oleracei 10g ~ 20g and Herba Moslae Soochowensis 20g ~ 30g.
The preparation method that present invention also offers described feed additive is:
The first step, is respectively crushed into powder by each traditional Chinese medicine composite component, is then mixed in proportion, be placed in extraction pot
In, adding the distilled water relative to mixture quality 7 ~ 9 times, first soak 30min ~ 1h, the way of distillation extracts volatile oil 4 ~ 6h；
Second step, the ethanol solution that volatile oil determining alcohol is 40% ~ 60% first step obtained dissolves completely, by β-ring
Dextrin adds the distilled water relative to its quality 2 ~ 4 times, mixing, the volatile oil dissolved before addition with ethanol, grinds to form pasty state
Thing, vacuum drying, it is re-fed in pulverizer being ground into the powder of 100 mesh ~ 150 mesh, it is thus achieved that volatile oil clathrate compound, volatile oil and β-
The mass ratio of cyclodextrin is 1:4 ~ 1:5；
3rd step, the Chinese medicine composition extract each for other in feed additive raw material and second step prepared-ring is stuck with paste
Spermatophore conjunction product is put into and is added a small amount of water in blender, and mix homogeneously is dried, it is thus achieved that feed additive.
The preparation method of described feedstuff particularly as follows:
The first step, is discharged into discharging pit by Semen Maydis, enters the thick cleaning of cylinder, dedusting after drag conveyor, bucket elevator
Roguing；
Second step, pulverizes various raw materials entrance pulverizer, and pulverizer sieve sheet is preferably 2.5mm；
3rd step, weighs various raw material on demand and enters burden balance with ratio；
4th step, is directly added into mixer by the raw material entered in burden balance and mixes, incorporation time 150s；
5th step, uses 4.2mm aperture ring film granulator to squeeze out pellet the raw material mixed, the modulation of granulation
Time is 15 ~ 30s, and refining temperature is 70 ~ 80 DEG C, steam pressure 0.5KPa, and particle length is 4 ~ 10mm；
6th step, the granule pelletized is completed to weigh by automatic packing machine, loads, package.
Beneficial effects of the present invention:
Feed additive that the present invention provides and comprise the feedstuff of this feed additive, by this feedstuff of feeding, can
Significantly to reduce the cholesterol level in egg yolk.
Detailed description of the invention
The invention provides a kind of feed additive for reducing cholesterol content in eggs, its raw material includes: different wheat
Bud oligosaccharide ,-glucosan, copper sulfate and Chinese medicine composition extract-cyclodextrin inclusion compound product.
In described feed additive the weight of each raw material be respectively dextrinosan 20g ~ 30g ,-Dextran 35 g ~
45g, copper sulfate 5g ~ 15g and Chinese medicine composition extract-cyclodextrin inclusion compound product 300g ~ 400g.
Further preferably, in described feed additive, the weight of each raw material is respectively dextrinosan 25g ,-glucosan
40g, copper sulfate 10g and Chinese medicine composition extract-cyclodextrin inclusion compound product 350g.
The preparation method of described feed additive is:
The first step, prepares Chinese medicine composition extract-cyclodextrin inclusion compound product；
Second step, the Chinese medicine composition extract each for other in feed additive raw material and the first step prepared-ring is stuck with paste
Spermatophore conjunction product is put into and is added a small amount of water in blender, and mix homogeneously is dried, it is thus achieved that feed additive.
Dextrinosan has promotion laying hen and produces and growth, reduces cholesterol and neutral fat in serum and meat egg
The each side such as content and function, the dextrinosan that the present invention provides is purchased from Zhengzhou Zhong Xin chemical products company limited.
-glucosan can effectively fetter intestinal cholesterol and be allowed to be combined with cholate, shortens when gastral
Between, increase the output of cholesterol in excrement and affect the metabolism of cholesterol, the present invention provide-glucosan is purchased from Shanghai Lu An
Bio tech ltd.
-cyclodextrin energy combined cholesterol and cholic acid, regulate small intestinal microbial activities, strengthens cholesterol and the conjunction of bile acid
Become and the excretion of feces, accelerate the conversion of body inner cholesterol.Therefore, the cholesterol that-cyclodextrin can obviously reduce in egg yolk contains
Amount.
The Chinese medicine composition extract component employing-cyclodextrin inclusion compound product that the present invention provides, can be effectively improved Chinese drug-treated group
Compound reduces the ability of cholesterol.
The crude drug of described Chinese medicine composition extract-cyclodextrin inclusion compound product include Herb Gynostemmae Pentaphylli, Flos Lonicerae, Flos Hibisci Rosae-Sinensis,
Folium Crataegi, Folium Ginkgo, Semen Cassiae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Rhizoma Polygonati Odorati, Herba Artemisiae Scopariae, Semen Lepidii (Semen Descurainiae), Rhizoma Curcumae Longae, Radix Et Rhizoma Rhei, Bulbus Allii Macrostemonis, Thallus Laminariae (Thallus Eckloniae), Fructus Schisandrae Chinensis,
Bulbus Allii, Herba Sonchi Oleracei and Herba Moslae Soochowensis.
Further, described Chinese medicine composition extract-cyclodextrin inclusion compound product is only made up of above-mentioned raw materials medicine.
The weight of described each crude drug is respectively Herb Gynostemmae Pentaphylli 55g ~ 65g, Flos Lonicerae 30g ~ 40g, Flos Hibisci Rosae-Sinensis 20g ~ 30g, mountain
Short, bristly hair or beard leaf 25g ~ 35g, Folium Ginkgo 20g ~ 30g, Semen Cassiae 20g ~ 30g, Radix Polygoni Multiflori 25g ~ 35g, Radix Salviae Miltiorrhizae 15g ~ 25g, Rhizoma Polygonati Odorati 10g ~
20g, Herba Artemisiae Scopariae 10g ~ 20g, Semen Lepidii (Semen Descurainiae) 25g ~ 35g, Rhizoma Curcumae Longae 25g ~ 35g, Radix Et Rhizoma Rhei 10g ~ 20g, Bulbus Allii Macrostemonis 10g ~ 20g, Thallus Laminariae (Thallus Eckloniae) 15g ~
25g, Fructus Schisandrae Chinensis 25g ~ 35g, Bulbus Allii 20g ~ 30g, Herba Sonchi Oleracei 10g ~ 20g and Herba Moslae Soochowensis 20g ~ 30g.
Further preferably, the weight of described each crude drug is respectively Herb Gynostemmae Pentaphylli 58g ~ 62g, Flos Lonicerae 33g ~ 37g, Flos Hibisci Rosae-Sinensis
23g ~ 27g, Folium Crataegi 28g ~ 32g, Folium Ginkgo 23g ~ 27g, Semen Cassiae 23g ~ 27g, Radix Polygoni Multiflori 28g ~ 32g, Radix Salviae Miltiorrhizae 18g ~ 22g,
Rhizoma Polygonati Odorati 13g ~ 17g, Herba Artemisiae Scopariae 13g ~ 17g, Semen Lepidii (Semen Descurainiae) 28g ~ 32g, Rhizoma Curcumae Longae 28g ~ 32g, Radix Et Rhizoma Rhei 13g ~ 17g, Bulbus Allii Macrostemonis 13g ~ 17g, elder brother
Cloth 18g ~ 22g, Fructus Schisandrae Chinensis 28g ~ 32g, Bulbus Allii 23g ~ 27g, Herba Sonchi Oleracei 13g ~ 17g and Herba Moslae Soochowensis 23g ~ 27g.
Most preferably, the weight of described each crude drug is respectively Herb Gynostemmae Pentaphylli 60g, Flos Lonicerae 35g, Flos Hibisci Rosae-Sinensis 25g, Folium Crataegi
30g, Folium Ginkgo 25g, Semen Cassiae 25g, Radix Polygoni Multiflori 30g, Radix Salviae Miltiorrhizae 20g, Rhizoma Polygonati Odorati 15g, Herba Artemisiae Scopariae 15g, Semen Lepidii (Semen Descurainiae) 30g, Rhizoma Curcumae Longae 30g,
Radix Et Rhizoma Rhei 15g, Bulbus Allii Macrostemonis 15g, Thallus Laminariae (Thallus Eckloniae) 20g, Fructus Schisandrae Chinensis 30g, Bulbus Allii 25g, Herba Sonchi Oleracei 15g and Herba Moslae Soochowensis 25g.
Herb Gynostemmae Pentaphylli: another name Herba Gynostemmatis, Pentapanax, gynostemma pentaphyllum makino, Herba Gynostemmatis, Herb Gynostemmae Pentaphylli, Radix Rhodiolae, the sweet bitter edible plant are climing, southerner
Ginseng, cold in nature, bitter in the mouth, to return lung, spleen, kidney channel, have QI invigorating, calm the nerves, effect of blood pressure lowering, for deficiency of vital energy and physically weak, few gas is weak；Vexed
Insomnia；Hypertension, Light-headedness；Viral hepatitis；Digestive tract tumor；Chronic bronchitiss etc. are demonstrate,proved, through modern medicine study
Finding, Herb Gynostemmae Pentaphylli principle active component is polysaccharide, flavonoid, saponins and microelement kind, and its effect is chiefly to facilitate people
Body fat class substance metabolism, nutrition human body cell, have good detoxicating, relieving inflammation effect simultaneously, be widely used in hyperlipidemia, fat
Fat liver, fat treatment.
Flos Lonicerae: latin name lonicerae japonicae flos, sweet in the mouth, cold in nature, enter the heart, lung, stomach, large intestine channel, have
The effect of heat-clearing and toxic substances removing, hold concurrently can eliminating pathogenic heat from blood to cure dysentery, be mainly used in affection due to external wind and heat, epidemic febrile disease pyretic toxicity is relatively contained, or epidemic febrile disease be from the beginning of pathogenic heat still
At the part of the body cavity above the diaphragm housing the heart and lungs the most descending time；Pyretic toxicity dysentery, stool hematochezia；Fever disease in summer is demonstrate,proved；The carbuncle sore of pyretic toxicity accumulation from the beginning of, the heat person of swelling and ache, and
Other skin infections, this thing has preferable antipyretic effect, has antiinflammatory action, can promote the phagocytic function of leukocyte, to multipleization
Purulence coccus and pathogenic entero becteria have stronger bacteriostasis.
Flos Hibisci Rosae-Sinensis: for the flower of Malvaceae Hibiscus plant Zhu Jin, sweet in the mouth, cold in nature, there is lung heat clearing, removing heat from blood, dampness removing, removing toxic substances
Effect, cures mainly cough due to lung-heat, hemoptysis, metrorrhagia, leucorrhea, dysentery, reddish and whitish turbid urine, and carbuncle skin infection etc. is demonstrate,proved.
Folium Crataegi: latin name Crataegi Folium, sour in the mouth, property is flat, returns Liver Channel, has blood circulation promoting and blood stasis dispelling, regulates the flow of vital energy and promote blood circulation,
Changing effect of turbid blood fat reducing, cure mainly qi depression to blood stasis, obstruction of qi in the chest and cardialgia, chest distress, palpitation and amnesia, vertigo and tinnitus, hyperlipidemia etc. is demonstrate,proved.
Folium Ginkgo: latin name Ginkgo Folium, sweet in the mouth, hardship, puckery, property is put down, and GUIXIN, lung meridian have blood circulation promoting and blood stasis dispelling, logical
Network pain relieving, astringes the lung and relievings asthma, and changes effect of turbid blood fat reducing, cures mainly obstruction of collaterals by blood stasis, obstruction of qi in the chest and cardialgia, apoplectic hemiplegia, cough and asthma due to lung deficiency, hyperlipidemia
Diseases etc. are demonstrate,proved.
Semen Cassiae: bitter in the mouth, cold nature, enter large intestine, kidney, Liver Channel, there is purging liver-fire, the effect of loosening bowel to relieve constipation, for mesh
Red puckery pain, the many tear of photophobia, dizziness of having a headache, poor vision, the card such as constipation, Semen Cassiae contain anthracene letones such as chrysophanol,
Rheum emodin, chrysophanic acid, emodin monoglucoside, rheum emodin anthraquinone, physcione, obtusin etc., these compositions make enterokinesia
Increase, thus promote the excretion of triglyceride, cholesterol, reduce fat absorption and there is the effect of Weight-reducing and lipid-lowering.
Radix Polygoni Multiflori: bitter in the mouth, sweet, puckery, slightly warm in nature, return liver, kidney channel, there is effect of nourishing the blood and yin, loosening bowel to relieve constipation, cure mainly blood
Empty Light-headedness；Cardiopalmus；Insomnia；The soreness of the waist and knees of the hepatic and renal YIN deficiency；Early whitening of beard and hair；Tinnitus；Seminal emission；Dryness of the intestine constipation；Chronic malaria body is empty；
Rubella pruritus；Carbuncle sore；Scrofula；Hemorrhoid etc. are demonstrate,proved, and Radix Polygoni Multiflori contains anthracene letones such as chrysophanol, rheum emodin, chrysophanic acid etc., these
Composition makes enterokinesia increase, thus promotes the excretion of triglyceride, cholesterol, reduces fat absorption and has the work of Weight-reducing and lipid-lowering
With.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature, enter the heart, Liver Channel, there is promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, clear away heart-fire relieving restlessness, supports
The effect of blood and tranquilizing mind, for menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, chest and abdomen twinge, pyretic arthralgia pain, skin infection swells and ache, vexed
Sleeplessness；Hepatosplenomegaly, angina pectoris etc. is demonstrate,proved.
Rhizoma Polygonati Odorati: sweet in the mouth, property is flat, enters lung, stomach warp, has nourishing YIN and moistening the lung, effect of nourishing the stomach to promote the production of body fluid, for cough caused by dryness, chronic cough, heat
The cards such as sick cloudy liquid consumes the dry throat and mouth of wound, and interior-heat is quenched one's thirst, deficiency of YIN diseases caused by exogenous pathogenic factor, dizzy dizziness, muscle arteries and veins spasm and pain, Rhizoma Polygonati Odorati can make peripheral blood vessel
And coronary artery expansion, and there are oxygen resistence, cardiotonic, moreover it is possible to blood fat reducing, blood sugar lowering and alleviation atheromatous plaque
Formed.
Herba Artemisiae Scopariae: acrid in the mouth, hardship, cold nature, returns spleen, stomach, liver, gallbladder meridian, cures mainly the cards such as jaundice, dysuria, eczema pruritus, medicine
Pharmacological research has function of gallbladder promoting, liver function protecting, and antipyretic, antiinflammatory, blood fat reducing, blood pressure lowering, coronary dilating etc. acts on.
Semen Lepidii (Semen Descurainiae): acrid in the mouth, bitter, cold in nature, enter lung, the heart, liver, stomach, bladder warp, there is eliminating the pathogens from the lung sending down the abnormal ascending QI, eliminating phlegm and relieving asthma, diuretic disappears
Swollen, let out by evil effect, cure mainly sputum and stop up the dyspnea and cough with excessive sputum of lung；Lung abscess；Edema；Chest and abdomen hydrops；Dysuria；Chronic pulmonary
Heart disease；Breathing heavily of heart failure is swollen；Scrofula tuberculosis etc. are demonstrate,proved, in Semen Lepidii (Semen Descurainiae) rich in linolenic acid, linoleic acid, the unsaturated lipid such as oleic acid
Fat acid, can promote that cholesterol converts to gallbladder fat acid, and the enterohepatic circulation of suppression gallbladder fat acid changes the distribution of internal cholesterol, subtracts
The content of cholesterol in insufficiency of blood tube wall, significantly reduces blood fat.
Rhizoma Curcumae Longae: latin name curcumae longae rhizoma, bitter in the mouth, pungent, warm in nature, enter Liver Channel, there is removing blood stasis circulation of qi promoting,
The cards such as effect of inducing menstruation to relieve menalgia, twinges for the breast side of body, amenorrhea, lump in the abdomen, rheumatism shoulder arm pain, tumbling and swelling, the Rhizoma Curcumae Longae in Rhizoma Curcumae Longae
Element has fall total plasma cholesterol, beta lipoprotein and the effect of triglyceride, and can make cholesterol and triglyceride in aorta
Content reduce.
Radix Et Rhizoma Rhei: bitter in the mouth, cold in nature, return stomach, large intestine, liver, spleen channel, there is the merit of purging heat to relax the bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation
Effect, cures mainly excess-heat constipation, the accumulation of heat feeling of stuffiness in chest, damp-heat dysentery, jaundice, gonorrhea, edema abdominal distention, dysuria, conjunctival congestion, laryngopharynx swelling and pain,
Aphtha of the mouth and tongue, gastropyretic vomiting, spit blood, spitting of blood, epistaxis, have blood in stool, hematuria, blood-retention, amenorrhea, puerperal the stagnant stomachache of the stasis of blood, lump in the abdomen, fall
Beating the cards such as damage, pyretic toxicity carbuncle and ulcer, erysipelas, scald, Radix Et Rhizoma Rhei has the effect of broad-spectrum antiseptic, can control the infection of wound surface, in Radix Et Rhizoma Rhei
Effective ingredient chrysophanic acid, rheum emodin, chrysophanol, physcione have and reduce blood pressure and the effect of cholesterol.
Bulbus Allii Macrostemonis: acrid in the mouth, hardship, warm in nature, return lung, the heart, stomach, large intestine channel, there is activating YANG and eliminating stagnation, effect of circulation of qi promoting intestinal stasis relieving, cure mainly
The thorough back of the body of obstruction of qi in the chest and cardialgia, breast gastral cavity painful abdominal mass is vexed, cough with asthma abundant expectoration, epigastric pain, lets out the cards such as weight after dysentery, leucorrhea, furuncle carbuncle, and Bulbus Allii Macrostemonis can reduce
Blood fat, especially the reduction effect to serum cholesterol, triglyceride are preferable, can reduce Serum LPO Levels, before raising simultaneously
Row ring cellulose content, thus play inhibition thrombosis, alleviate the effect of atherosclerotic lesion.
Thallus Laminariae (Thallus Eckloniae): salty in the mouth, cold in nature, to return liver, stomach, kidney channel, there is hard masses softening and resolving, effect of expectorant diuretic, for goiter, scrofula
Scrofula, painful and swollen testis, the card such as phlegm retention edema, it can suppress hyperlipidemia chicken serum T-CHOL significantly.
Fructus Schisandrae Chinensis: sour in the mouth, sweet, warm in nature, enter lung, the heart, kidney channel, there is convergence astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, the work of kidney calming
With, for chronic cough dyspnea due to deficiency, emission, enuresis frequent micturition, incessant chronic diarrhea, spontaneous perspiration, night sweat, Tianjin wound is thirsty, and deficient pulse of losing heart, interior-heat disappears
Yearningly, palpitation and insomnia.Fructus Schisandrae Chinensis has antiinflammation, and Fructus Schisandrae Chinensis can substantially suppress the increasing of ovariectomized female rats food ration and weight
Add, reduce total plasma cholesterol, triglyceride and high-density protein.
Bulbus Allii: warm in nature, acrid in the mouth is put down；Enter spleen, stomach, lung meridian, there is warming middle-JIAO and help digestion, row stagnant gas, warming the spleen and stomach, removing food stagnancy, detoxify, kill
Effect of worm, cure mainly eating accumulation, coldness and pain in the epigastrium, edema distension, have loose bowels, dysentery, malaria, pertussis, swollen ulcer drug, white bald tinea
Skin ulcer, snake bite and insect sting and the disease such as ancylostome, pinworm, the allicin in Bulbus Allii is diallyl trisulfide, stablizes and has fall gallbladder
Sterin etc. act on.
Herba Sonchi Oleracei: for the herb of Compositae sonchus plant Herba Sonchi Oleracei, bitter in the mouth, cold in nature, GUIXIN, spleen, stomach, large intestine channel, have
Heat-clearing and toxic substances removing, effect of cooling blood for hemostasis, cure mainly enteritis, dysentery, jaundice, stranguria, laryngopharynx swelling and pain, aphtha, acute mastitis, worm venom,
Spit blood, hemoptysis, hematuria, to have blood in stool, metrorrhagia etc. is demonstrate,proved.
Herba Moslae Soochowensis: warm in nature, acrid in the mouth, there is dispelling summer-heat from superficies of the body, effect of regulating QI to relieve pain, cure mainly flu, heatstroke, eruptive disease, gastric qi
Bitterly, the card such as laryngopharynx swelling and pain.
Present invention also offers the preparation method of described Chinese medicine composition extract-cyclodextrin inclusion compound product, particularly as follows:
The first step, is respectively crushed into powder by each traditional Chinese medicine composite component, is then mixed in proportion, be placed in extraction pot
In, adding the distilled water relative to mixture quality 7 ~ 9 times, first soak 30min ~ 1h, the way of distillation extracts volatile oil 4 ~ 6h；
Second step, the ethanol solution that volatile oil determining alcohol is 40% ~ 60% first step obtained dissolves completely, by β-ring
Dextrin adds the distilled water relative to its quality 2 ~ 4 times, mixing, the volatile oil dissolved before addition with ethanol, grinds to form pasty state
Thing, vacuum drying, it is re-fed in pulverizer being ground into the powder of 100 mesh ~ 150 mesh, it is thus achieved that inclusion product, volatile oil and β-ring are stuck with paste
The mass ratio of essence is 1:4 ~ 1:5.
Present invention also offers a kind of feedstuff for reducing cholesterol content in eggs, it includes Semen Maydis, Semen Tritici aestivi, bean
The dregs of rice, cottonseed meal, calcium hydrogen phosphate, threonine, Adeps Sus domestica, choline chloride, glycine betaine, Sal, vitamin premix DV22H and the present invention carry
The feed additive for reducing cholesterol content in eggs of confession.
In described feedstuff the weight of each raw material be respectively Semen Maydis 50g ~ 55g, Semen Tritici aestivi 8g ~ 12g, bean cake 2g ~ 4g, cottonseed meal 3g ~
5g, calcium hydrogen phosphate 0.5g ~ 1.5g, threonine 0.1g ~ 0.3g, Adeps Sus domestica 1g ~ 3g, choline chloride 0.05g ~ 0.15g, glycine betaine
What 0.05g ~ 0.15g, Sal 0.3g ~ 0.5g, vitamin premix DV22H 0.2g ~ 0.4g and the present invention provided is used for reducing chicken
Feed additive 2g ~ the 5g of cholesterol level in egg.
Further preferably, in described feedstuff the total amount of each raw material be respectively Semen Maydis 53g, Semen Tritici aestivi 10g, bean cake 3g, cottonseed meal 4g,
Calcium hydrogen phosphate 1g, threonine 0.2g, Adeps Sus domestica 2g, choline chloride 0.1g, glycine betaine 0.1g, Sal 0.4g, vitamin premix
The feed additive 3g for reducing cholesterol content in eggs that DV22H 0.3g and the present invention provide.
The preparation method of described feedstuff particularly as follows:
The first step, is discharged into discharging pit by Semen Maydis, enters the thick cleaning of cylinder, dedusting after drag conveyor, bucket elevator
Roguing；
Second step, pulverizes various raw materials entrance pulverizer, and pulverizer sieve sheet is preferably 2.5mm；
3rd step, weighs various raw material on demand and enters burden balance with ratio；
4th step, is directly added into mixer by the raw material entered in burden balance and mixes, incorporation time 150s；
5th step, uses 4.2mm aperture ring film granulator to squeeze out pellet the raw material mixed, the modulation of granulation
Time is 15 ~ 30s, and refining temperature is 70 ~ 80 DEG C, steam pressure 0.5KPa, and particle length is 4 ~ 10mm；
6th step, the granule pelletized is completed to weigh by automatic packing machine, loads, package.
Described DV22H is the vitamin premixed feed that Qingdao Hemei Feed Co., Ltd. produces, and is trade name, on market
Can buy, main component vitamin A: 4000-6500KIU, vitamin D3；975-2025 KIU, vitamin K3: 1050-
2250KIU, vitamin B1: >=900mg, vitamin E: >=8000IU, vitamin B2: >=2700mg, pantothenic acid: >=4500mg, cigarette
Acid: >=14000mg, carrier is dephenolization cottonseed protein and corn starch.
Embodiment is below used to describe embodiments of the present invention in detail, whereby to the present invention how application technology means
Solve technical problem, and the process that realizes reaching technique effect can fully understand and implement according to this.
Embodiment 1 Chinese medicine composition extract-cyclodextrin inclusion compound product 1
By Herb Gynostemmae Pentaphylli 60g, Flos Lonicerae 35g, Flos Hibisci Rosae-Sinensis 25g, Folium Crataegi 30g, Folium Ginkgo 25g, Semen Cassiae 25g, Radix Polygoni Multiflori
30g, Radix Salviae Miltiorrhizae 20g, Rhizoma Polygonati Odorati 15g, Herba Artemisiae Scopariae 15g, Semen Lepidii (Semen Descurainiae) 30g, Rhizoma Curcumae Longae 30g, Radix Et Rhizoma Rhei 15g, Bulbus Allii Macrostemonis 15g, Thallus Laminariae (Thallus Eckloniae) 20g, Fructus Schisandrae Chinensis
30g, Bulbus Allii 25g, Herba Sonchi Oleracei 15g and Herba Moslae Soochowensis 25g are respectively crushed into powder, are then mixed in proportion, and are placed in extraction pot, add
The distilled water of 4kg, first soaks 1h, and the way of distillation extracts volatile oil 5h, by the ethanol solution that volatile oil determining alcohol is 50% of acquisition
Dissolve completely, the beta-schardinger dextrin-of 2kg is added the distilled water of 6kg, mixing, the volatile oil dissolved with ethanol before addition, grinds
Become pastel, vacuum drying, be re-fed in pulverizer being ground into the powder of 150 mesh, it is thus achieved that inclusion product 1.
Embodiment 2 Chinese medicine composition extract-cyclodextrin inclusion compound product 2
By Herb Gynostemmae Pentaphylli 58g, Flos Lonicerae 33g, Flos Hibisci Rosae-Sinensis 23g, Folium Crataegi 28g, Folium Ginkgo 23g, Semen Cassiae 23g, Radix Polygoni Multiflori
28g, Radix Salviae Miltiorrhizae 18g, Rhizoma Polygonati Odorati 13g, Herba Artemisiae Scopariae 13g, Semen Lepidii (Semen Descurainiae) 28g, Rhizoma Curcumae Longae 28g, Radix Et Rhizoma Rhei 13g, Bulbus Allii Macrostemonis 13g, Thallus Laminariae (Thallus Eckloniae) 18g, Fructus Schisandrae Chinensis
28g, Bulbus Allii 23g, Herba Sonchi Oleracei 13g and Herba Moslae Soochowensis 23g are respectively crushed into powder, are then mixed in proportion, and are placed in extraction pot, add
The distilled water of 4kg, first soaks 1h, and the way of distillation extracts volatile oil 5h, by the ethanol solution that volatile oil determining alcohol is 50% of acquisition
Dissolve completely, the beta-schardinger dextrin-of 2kg is added the distilled water of 6kg, mixing, the volatile oil dissolved with ethanol before addition, grinds
Become pastel, vacuum drying, be re-fed in pulverizer being ground into the powder of 150 mesh, it is thus achieved that inclusion product 2.
Embodiment 3 Chinese medicine composition extract-cyclodextrin inclusion compound product 3
By Herb Gynostemmae Pentaphylli 62g, Flos Lonicerae 37g, Flos Hibisci Rosae-Sinensis 27g, Folium Crataegi 32g, Folium Ginkgo 27g, Semen Cassiae 27g, Radix Polygoni Multiflori
32g, Radix Salviae Miltiorrhizae 22g, Rhizoma Polygonati Odorati 17g, Herba Artemisiae Scopariae 17g, Semen Lepidii (Semen Descurainiae) 32g, Rhizoma Curcumae Longae 32g, Radix Et Rhizoma Rhei 17g, Bulbus Allii Macrostemonis 17g, Thallus Laminariae (Thallus Eckloniae) 22g, Fructus Schisandrae Chinensis
32g, Bulbus Allii 27g, Herba Sonchi Oleracei 17g and Herba Moslae Soochowensis 27g are respectively crushed into powder, are then mixed in proportion, and are placed in extraction pot, add
The distilled water of 4kg, first soaks 1h, and the way of distillation extracts volatile oil 5h, by the ethanol solution that volatile oil determining alcohol is 50% of acquisition
Dissolve completely, the beta-schardinger dextrin-of 2kg is added the distilled water of 6kg, mixing, the volatile oil dissolved with ethanol before addition, grinds
Become pastel, vacuum drying, be re-fed in pulverizer being ground into the powder of 150 mesh, it is thus achieved that inclusion product 3.
Embodiment 4 toxicological experiment
Taking ICR mice, body weight, at 25～30 grams, is randomly divided into 2 groups by body weight, often group 20, and male and female half and half are real by 50g
Executing the inclusion product 1 of example 1 preparation, be dissolved in the water of 50ml, to Mouse oral solutions for administration, dosage is 0.8ml/, the
One group is administered inclusion product 1, and second group gavages distilled water.Continuous Observation 20 days after administration, all mices of result are strong deposits, and it is lived
Dynamic, diet, hair, Excreta are no abnormal, have no toxic reaction.White mouse oral cavity and damaged skin are carried out zest examination
Test, there are no irritative response and other untoward reaction.
Toxicity test proves, this most toxic effect of Chinese medicine composition additive and untoward reaction, clinical practice safely may be used
Lean on.
Embodiment 5 feed additive
Inclusion product 1 prepared by 350g embodiment 1,25g dextrinosan (Zhengzhou Zhong Xin chemical products company limited
There is provided) ,-Gentran 40 g (offers of Lu An bio tech ltd, Shanghai), copper sulfate 10g put in blender and add on a small quantity
Water, mix homogeneously, dry, it is thus achieved that feed additive.
Embodiment 6 feedstuff 1
Semen Maydis 53g is discharged into discharging pit, the entrance thick cleaning of cylinder after drag conveyor, bucket elevator, dedusting roguing,
By the Semen Maydis of roguing, Semen Tritici aestivi 10g, bean cake 3g, cottonseed meal 4g, calcium hydrogen phosphate 1g, threonine 0.2g, Adeps Sus domestica 2g, choline chloride 0.1g,
The feed additive 1 of glycine betaine 0.1g, Sal 0.4g, vitamin premix DV22H 0.3g and 3g embodiment 5 preparation sends into powder
Broken machine is pulverized, and pulverizer sieve sheet is preferably 2.5mm；Various raw materials are entered burden balance, the raw material in burden balance will be entered
It is directly added into mixer to mix, incorporation time 150s, the raw material mixed is used the ring film granulator extruding of 4.2mm aperture
Going out pellet, the modulation time of granulation is 20s, and refining temperature is 80 DEG C, steam pressure 0.5KPa, and particle length is 6mm, system
The good granule of grain is completed to weigh by automatic packing machine, loads, package.
Comparative example 1 feedstuff 2
Semen Maydis 53g is discharged into discharging pit, the entrance thick cleaning of cylinder after drag conveyor, bucket elevator, dedusting roguing,
By the Semen Maydis of roguing, Semen Tritici aestivi 10g, bean cake 3g, cottonseed meal 4g, calcium hydrogen phosphate 1g, threonine 0.2g, Adeps Sus domestica 2g, choline chloride 0.1g,
Glycine betaine 0.1g, Sal 0.4g, vitamin premix DV22H 0.3g send into pulverizer and pulverize, and pulverizer sieve sheet is preferably
2.5mm；Various raw materials are entered burden balance, the raw material entered in burden balance is directly added into mixer and mixes, during mixing
Between 150s, use 4.2mm aperture ring film granulator to squeeze out pellet the raw material mixed, the modulation time of granulation is
20s, refining temperature is 80 DEG C, steam pressure 0.5KPa, and particle length is 6mm, and the granule pelletized is completed by automatic packing machine
Weigh, load, package.
Comparative example 2 feedstuff 3
Semen Maydis 53g is discharged into discharging pit, the entrance thick cleaning of cylinder after drag conveyor, bucket elevator, dedusting roguing,
By the Semen Maydis of roguing, Semen Tritici aestivi 10g, bean cake 3g, cottonseed meal 4g, calcium hydrogen phosphate 1g, threonine 0.2g, Adeps Sus domestica 2g, choline chloride 0.1g,
Glycine betaine 0.1g, Sal 0.4g, (Zhengzhou crowd believes that chemical products have to vitamin premix DV22H 0.3g, 2g dextrinosan
Limit company provide) ,-bextran 45 g (offers of Lu An bio tech ltd, Shanghai), copper sulfate 1g feeding pulverizer carry out powder
Broken, pulverizer sieve sheet is preferably 2.5mm；Various raw materials are entered burden balance, the raw material entered in burden balance is directly added into mixed
Conjunction machine mixes, incorporation time 150s, uses 4.2mm aperture ring film granulator to squeeze out granule the raw material mixed and raises
Material, the modulation time of granulation is 20s, and refining temperature is 80 DEG C, steam pressure 0.5KPa, and particle length is 6mm, pelletized
Grain is completed to weigh by automatic packing machine, loads, package.
Effect test
Experimental animal and packet
Select that 40 week old are healthy, body weight and close Luo Manbai laying hen 450 plumage of laying rate, use single-factor completely with
Machine designs, and is classified as 3 groups: matched group 1, feeds the feedstuff 2 of comparative example 1;Matched group 2, the feedstuff of feeding comparative example 2
3;Test group, the dietetic therapy 1 of feeding embodiment 6.Often 10 repetitions of group, each repetition 15 plumage chicken.Experimental period 49 d, Qi Zhongqian
Within 7 days, it is preliminary trial period, is just trying phase 42 d.
Feeding and management
All examination chickens use 3 layers of staged to raise in cages, and respectively repeat to be uniformly distributed in hen house.Free choice feeding, drinking-water, every day is permanent
Determine illumination 16 h.Every day clear excrement and receive each 2 times of egg, program carries out chicken immunity and column home is sterilized routinely.
Testing index and method
The 21st day experimental period and the 42nd day, randomly draw 10 pieces of eggs (2 pieces/repeat), mark from often group respectively
On note group, the date, it is placed in 4 DEG C of Refrigerator stores, is used for measuring cholesterol level of vitellus.Before mensuration, every piece of egg is weighed.
To egg yolk correct amount, and calculate egg yolk relative weight.
Egg yolk relative weight (%)=(egg yolk weight/egg size) × 100.
Egg cholesterol amount cholesterol level of vitellus and 2 indexs of shell egg cholesterol level represent.Wherein, egg
Yellow cholesterol level refers to the content of cholesterol in every gram of egg yolk, and shell egg cholesterol level is the content of cholesterol in every piece of egg.
Use T-CHOL quantification kit (Beijing North Hua Taikang clinical reagent company limited) and microplate reader (Nanjing East China Electronics Co., Ltd
Medical equipment Co., Ltd of group) measure shell egg and cholesterol level of vitellus.Additional mark-on recovery test is to detect knot
The accuracy of fruit.
Data process&analysis
Use SAS/PC(6.0) software, by one factor analysis of variance method, the test data of indices is carried out statistical
Analysis.Significant difference person, carries out multiple comparisons with minimum notable extreme difference q method of inspection.
The feed additive impact on cholesterol level of vitellus, the results are shown in Table 1.
The impact on cholesterol level of vitellus of table 1 feed additive
| Time | Project | Matched group 1 | Matched group 2 | Test group |
| 21st day | Egg yolk relative weight % | 29.18+0.72 | 28.96+0.53 | 29.01+0.63 |
| Cholesterol level of vitellus (mg/g) | 13.10+0.29 | 11.92+0.35 | 9.23+0.30 | |
| Shell egg cholesterol level (mg/g) | 229.26+4.99 | 206.17+6.03 | 186.35+5.61 | |
| 42nd day | Egg yolk relative weight % | 28.80+0.68 | 29.26+0.59 | 28.97+0.62 |
| Cholesterol level of vitellus (mg/g) | 12.99+0.51 | 11.25+0.27 | 7.61+0.19 | |
| Shell egg cholesterol level (mg/g) | 226.51+5.31 | 196.52+5.09 | 171.41+5.29 |
As it can be seen from table 1 the feedstuff using the present invention to provide can significantly reduce egg yolk gallbladder at the 21st day and the 42nd day
The content of sterin.
All above-mentioned primary these intellectual properties of enforcement, do not set this new product of enforcement limiting other forms
And/or new method.Those skilled in the art will utilize this important information, and foregoing is revised, to realize similar execution feelings
Condition.But, all modifications or transformation belong to the right of reservation based on new product of the present invention.
The above, be only presently preferred embodiments of the present invention, is not the restriction that the present invention makees other form, appoints
What those skilled in the art changed possibly also with the technology contents of the disclosure above or be modified as equivalent variations etc.
Effect embodiment.But every without departing from technical solution of the present invention content, the technical spirit of the foundation present invention is to above example institute
Any simple modification, equivalent variations and the remodeling made, still falls within the protection domain of technical solution of the present invention.
Claims (3)
1. one kind for reducing the feedstuff of cholesterol content in eggs, it is characterised in that: include Semen Maydis, Semen Tritici aestivi, bean cake, cottonseed meal,
Calcium hydrogen phosphate, threonine, Adeps Sus domestica, choline chloride, glycine betaine, Sal, vitamin premix DV22H and be used for reducing gallbladder in egg
The feed additive of sterin content；
In described feedstuff, the weight of each raw material is respectively Semen Maydis 50g ~ 55g, Semen Tritici aestivi 8g ~ 12g, bean cake 2g ~ 4g, cottonseed meal 3g ~ 5g, phosphorus
Acid hydrogen calcium 0.5g ~ 1.5g, threonine 0.1g ~ 0.3g, Adeps Sus domestica 1g ~ 3g, choline chloride 0.05g ~ 0.15g, glycine betaine 0.05g ~
0.15g, Sal 0.3g ~ 0.5g, vitamin premix DV22H 0.2g ~ 0.4g and for reducing raising of cholesterol content in eggs
Feed additives 2g ~ 5g；
The raw material of the described feed additive for reducing cholesterol content in eggs is by dextrinosan ,-glucosan, sulfur
Acid copper and Chinese medicine composition extract-cyclodextrin inclusion compound product are constituted；
In described feed additive, the weight of each raw material is respectively dextrinosan 20g ~ 30g ,-Dextran 35 g ~ 45g, sulfur
Acid copper 5g ~ 15g and Chinese medicine composition extract-cyclodextrin inclusion compound product 300g ~ 400g；
The crude drug of described Chinese medicine composition extract-cyclodextrin inclusion compound product is by Herb Gynostemmae Pentaphylli, Flos Lonicerae, Flos Hibisci Rosae-Sinensis, Fructus Crataegi
Leaf, Folium Ginkgo, Semen Cassiae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Rhizoma Polygonati Odorati, Herba Artemisiae Scopariae, Semen Lepidii (Semen Descurainiae), Rhizoma Curcumae Longae, Radix Et Rhizoma Rhei, Bulbus Allii Macrostemonis, Thallus Laminariae (Thallus Eckloniae), Fructus Schisandrae Chinensis, big
Bulbus Allii, Herba Sonchi Oleracei and Herba Moslae Soochowensis are constituted；
The crude drug proportioning of described Chinese medicine composition extract-cyclodextrin inclusion compound product is respectively Herb Gynostemmae Pentaphylli 55g ~ 65g, gold silver
Flower 30g ~ 40g, Flos Hibisci Rosae-Sinensis 20g ~ 30g, Folium Crataegi 25g ~ 35g, Folium Ginkgo 20g ~ 30g, Semen Cassiae 20g ~ 30g, Radix Polygoni Multiflori 25g ~
35g, Radix Salviae Miltiorrhizae 15g ~ 25g, Rhizoma Polygonati Odorati 10g ~ 20g, Herba Artemisiae Scopariae 10g ~ 20g, Semen Lepidii (Semen Descurainiae) 25g ~ 35g, Rhizoma Curcumae Longae 25g ~ 35g, Radix Et Rhizoma Rhei 10g ~
20g, Bulbus Allii Macrostemonis 10g ~ 20g, Thallus Laminariae (Thallus Eckloniae) 15g ~ 25g, Fructus Schisandrae Chinensis 25g ~ 35g, Bulbus Allii 20g ~ 30g, Herba Sonchi Oleracei 10g ~ 20g and Herba Moslae Soochowensis 20g ~
30g。
2. feedstuff as claimed in claim 1, it is characterised in that: in described feedstuff, the weight of each raw material is respectively Semen Maydis 53g, little
Wheat 10g, bean cake 3g, cottonseed meal 4g, calcium hydrogen phosphate 1g, threonine 0.2g, Adeps Sus domestica 2g, choline chloride 0.1g, glycine betaine 0.1g, Sal
0.4g, vitamin premix DV22H 0.3g and for reducing the feed additive 3g of cholesterol content in eggs.
3. the preparation method of feedstuff described in claim 1 or 2, it is characterised in that including:
The first step, is discharged into discharging pit by Semen Maydis, enters the thick cleaning of cylinder, dedusting roguing after drag conveyor, bucket elevator；
Second step, enters pulverizer by above-mentioned feed additive and remaining various raw material and pulverizes, and pulverizer sieve sheet is preferred
For 2.5mm；
3rd step, weighs various raw material on demand and enters burden balance with ratio；
4th step, is directly added into mixer by the raw material entered in burden balance and mixes, incorporation time 150s；
5th step, uses 4.2mm aperture ring film granulator to squeeze out pellet the raw material mixed, the modulation time of granulation
Being 15 ~ 30s, refining temperature is 70 ~ 80 DEG C, steam pressure 0.5KPa, and particle length is 4 ~ 10mm；
6th step, the granule pelletized is completed to weigh by automatic packing machine, loads, package.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410440694.0A CN104161194B (en) | 2014-09-02 | 2014-09-02 | For reducing the feedstuff of cholesterol content in eggs |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410440694.0A CN104161194B (en) | 2014-09-02 | 2014-09-02 | For reducing the feedstuff of cholesterol content in eggs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104161194A CN104161194A (en) | 2014-11-26 |
| CN104161194B true CN104161194B (en) | 2016-08-17 |
Family
ID=51905291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410440694.0A Expired - Fee Related CN104161194B (en) | 2014-09-02 | 2014-09-02 | For reducing the feedstuff of cholesterol content in eggs |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104161194B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104642811B (en) * | 2015-02-15 | 2018-08-21 | 西安格润牧业发展有限公司 | The egg feedstuff of cholesterol and the production method of low-cholesterol egg in a kind of reduction egg |
| CN105028930B (en) * | 2015-08-12 | 2018-11-27 | 昆明理工大学 | A kind of Chinese herbal feed reducing egg cholesterol |
| CN106260717A (en) * | 2016-08-19 | 2017-01-04 | 臧明磊 | A kind of feed additive reducing cholesterol level in egg and chicken and preparation method |
| CN107751557A (en) * | 2016-08-22 | 2018-03-06 | 北京大伟嘉生物技术股份有限公司 | A kind of Chinese herb feed additive for reducing egg cholesterol and its application |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1751587A (en) * | 2004-09-22 | 2006-03-29 | 张登民 | Feed additive for domestic animals and birds for improving their disease-resistance and lowering cholesterol |
| CN101213952B (en) * | 2008-01-15 | 2010-07-07 | 济南康众医药科技开发有限公司 | Method for producing low cholesterol egg without residual agricultural chemical |
| CN101579042B (en) * | 2009-06-22 | 2011-09-28 | 西北农林科技大学 | Laying-hen feed additive |
| CN102389053A (en) * | 2011-11-12 | 2012-03-28 | 天津硒艾格生物科技有限公司 | Production method of eggs with low cholesterol, abundant selenium and abundant carotene |
| CN103099058B (en) * | 2012-12-13 | 2014-07-02 | 济南和美华饲料有限公司 | Complete feed for egg producing period |
| CN103404701B (en) * | 2013-08-26 | 2015-08-05 | 成都乾坤动物药业有限公司 | A kind ofly improve veterinary composition of poultry mouthfeel and its production and use |
| CN103598427B (en) * | 2013-10-14 | 2015-12-02 | 张绪伟 | For reducing feed addictive and the feed of cholesterol content in eggs |
| CN104206905B (en) * | 2014-09-02 | 2016-09-14 | 赵建红 | For reducing the feed additive of cholesterol content in eggs |
-
2014
- 2014-09-02 CN CN201410440694.0A patent/CN104161194B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN104161194A (en) | 2014-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103141709B (en) | Carp feed and preparation method thereof | |
| CN104206905B (en) | For reducing the feed additive of cholesterol content in eggs | |
| CN102940155B (en) | Duckling feed for cherry valley duck and preparation method thereof | |
| CN103598427B (en) | For reducing feed addictive and the feed of cholesterol content in eggs | |
| CN102139084B (en) | Chinese medicinal composition for treating fatty liver and preparation method and application thereof | |
| CN103385392B (en) | Novel laying hen feed | |
| CN104222696B (en) | For treating feedstuff and the pharmaceutical preparation of fish gill rot | |
| CN102526318A (en) | Chinese medicinal composition for preventing and treating chicken diseases and preparation method thereof | |
| CN104286422A (en) | Composite poultry feed additive with high anti-disease property | |
| CN104161194B (en) | For reducing the feedstuff of cholesterol content in eggs | |
| CN105265827A (en) | Wheat type broiler feed and preparation method thereof | |
| CN102397484A (en) | Pure Chinese medicinal composition for treating ascites syndrome of broilers and preparation method thereof | |
| CN103977372A (en) | Traditional Chinese medicine additive used for treating porcine epizootic diarrhea and preparing method thereof | |
| CN103768529A (en) | Traditional Chinese medicine composition for treating postchole cystomy syndrome and application thereof | |
| CN102526639B (en) | Chinese medicinal composition for treating hyperlipidemia and preparation method thereof | |
| CN104398912A (en) | Medicine capable of moistening lung, relieving cough and reducing sputum and preparation method of medicine | |
| CN103444957A (en) | Health tea electuary for treating constipation based on food therapy | |
| CN104771585A (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
| CN110141656A (en) | A kind of Fuke Tiaojing blood-nourishing Chinese medicine composition and preparation method thereof | |
| CN103860844B (en) | A kind of Chinese medicine preparation for the treatment of chronic colitis and preparation method thereof | |
| CN103432335B (en) | Medicament for treating chyluria and preparation method thereof | |
| CN101869700A (en) | Chinese medicinal oral liquid for treating tumour and preparation method thereof | |
| CN106620266A (en) | Traditional Chinese medicine composition for treating mycoplasmal pneumonia of swine | |
| CN105582379A (en) | Traditional Chinese medicine composition for treating liver-stomach disharmony and preparation method of traditional Chinese medicine composition | |
| CN105327176A (en) | Traditional Chinese medicine composition for preventing and curing silicosis and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhao Jianhong Inventor after: Guo Xiaochuan Inventor before: Zhao Jianhong |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160615 Address after: 311899 Zhejiang Province, Zhuji city Jiyang Street No. 88 over 800 Applicant after: Guo Xiaochuan Address before: 312099, Shaoxing, Zhejiang province 93-206 Yue Yuan Chi Yuan court Applicant before: Zhao Jianhong |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Guo Wei Inventor after: Guo Xiaochuan Inventor before: Zhao Jianhong Inventor before: Guo Xiaochuan |
|
| COR | Change of bibliographic data | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170303 Address after: 300000 Tianjin Binhai New Area, Hangu source, building No. 4, No. 203 Patentee after: Guo Wei Address before: 311899 Zhejiang Province, Zhuji city Jiyang Street No. 88 over 800 Patentee before: Guo Xiaochuan |
|
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Guo Wei Inventor before: Guo Wei Inventor before: Guo Xiaochuan |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 Termination date: 20170902 |